SynthesisInternational ophthalmology2025
Rhegmatogenous retinal detachment associated with spontaneous suprachoroidal hemorrhage in high myopia patients: two case reports and systematic review.
Synthesis in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThis study aimed to compare the clinical presentation, treatment, and prognosis of two patients with high myopia who suffered rhegmatogenous retinal detachment (RRD) associated with spontaneous suprachoroidal hemorrhage (SSCH) with similar cases discussed in the literature.
methodsThe clinical data of two high myopia patients with RRD associated with SSCH were extracted. A systematic review of the literature was conducted using various databases. The clinical characteristics, treatments, and prognoses of the two cases treated at our hospital were compared with the case reports described in the literature.
resultsBoth patients presented at our hospital with elongated axial eye lengths and hypotony. The patients underwent 23G recombinant tissue plasminogen activator (r-tPA)-assisted vitrectomy combined with silicone oil (SO) injection. The literature review identified seven similar cases. The intraocular pressure (IOP) in the literature cases ranged from 2 to 10 mmHg. Seven patients discussed in the literature had elongated axial lengths, of whom six had axial eye lengths measuring over 30 mm. All cases were managed with vitrectomy, and five out of the seven cases subsequently developed proliferative vitreoretinopathy (PVR).
conclusionRRD associated with SCH is an exceptionally rare condition, often leading to poor final visual outcomes. Long axial length appears to be the primary risk factor. Most patients present with hypotony, reflecting the underlying pathogenesis. r-tPA-assisted vitrectomy performed within 7 days following diagnosis may help reduce SCH and improve the likelihood of successful retinal reattachment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.